These findings indicate that sustained NF-κB activation in airway epithelium results in COPD-like pathology followed by induction of lung tumorigenesis, illustrating a mechanistic link between COPD and lung cancer via the NF-κB pathway. Here, NFKB1 is linked to lung carcinoma.